Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in one-on-one investor meetings at the following conference:
Kempen Life Sciences Conference
- Dates: April 15 –16, 2026
- Location: Amsterdam, Netherlands
| Press release in English | 139 KB |
| Communiqué de presse en français | 131.63 KB |